Global Toxin Market Size, Share, Trends and Forecast 2022-2030

Description

Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.
Industry Insights

Due to the COVID-19 pandemic, the global Toxin market size is estimated to be worth US$ 4700 million in 2021 and is forecast to a readjusted size of US$ 9111.6 million by 2028 with a CAGR of 9.8% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Toxin market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Toxin landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Global Toxin key players include Allergan, LIBP, Hugel, Ipsen, Medytox, etc. Global top five manufacturers hold a share about 90%.

Europe is the largest market, with a share over 10%, followed by APAC, and Middle East & Africa, both have a share over 20%.

In terms of product, 50U is the largest segment, with a share about 55%. And in terms of application, the largest application is Cosmetic, followed by Medical, etc.

This report focuses on Toxin volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Toxin market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and South Korea, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Toxin market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

50U

100U

Others

Segment by Application

Medical

Cosmetic

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Allergan

Ipsen

Medytox

LIBP

Merz Pharmaceuticals

US World Meds

Hugel

Daewoong

TABLE OF CONTENT

1 Toxin Market Overview
1.1 Product Overview and Scope of Toxin

1.2 Toxin Segment by Type

1.2.1 Global Toxin Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 50U

1.2.3 100U

1.2.4 Others

1.3 Toxin Segment by Application

1.3.1 Global Toxin Sales Comparison by Application: (2022-2028)

1.3.2 Medical

1.3.3 Cosmetic

1.4 Global Toxin Market Size Estimates and Forecasts

1.4.1 Global Toxin Revenue 2017-2028

1.4.2 Global Toxin Sales 2017-2028

1.4.3 Toxin Market Size by Region: 2017 Versus 2021 Versus 2028

2 Toxin Market Competition by Manufacturers

2.1 Global Toxin Sales Market Share by Manufacturers (2017-2022)

2.2 Global Toxin Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Toxin Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Toxin Manufacturing Sites, Area Served, Product Type

2.5 Toxin Market Competitive Situation and Trends

2.5.1 Toxin Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Toxin Players Market Share by Revenue

2.5.3 Global Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Toxin Retrospective Market Scenario by Region

3.1 Global Toxin Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Toxin Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Toxin Market Facts & Figures by Country

3.3.1 North America Toxin Sales by Country

3.3.2 North America Toxin Revenue by Country

3.3.3 United States

3.3.4 Canada

3.4 Europe Toxin Market Facts & Figures by Country

3.4.1 Europe Toxin Sales by Country

3.4.2 Europe Toxin Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Toxin Market Facts & Figures by Region

3.5.1 Asia Pacific Toxin Sales by Region

3.5.2 Asia Pacific Toxin Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 China Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America Toxin Market Facts & Figures by Country

3.6.1 Latin America Toxin Sales by Country

3.6.2 Latin America Toxin Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.6.6 Colombia

3.7 Middle East and Africa Toxin Market Facts & Figures by Country

3.7.1 Middle East and Africa Toxin Sales by Country

3.7.2 Middle East and Africa Toxin Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Toxin Historic Market Analysis by Type

4.1 Global Toxin Sales Market Share by Type (2017-2022)

4.2 Global Toxin Revenue Market Share by Type (2017-2022)

4.3 Global Toxin Price by Type (2017-2022)

5 Global Toxin Historic Market Analysis by Application

5.1 Global Toxin Sales Market Share by Application (2017-2022)

5.2 Global Toxin Revenue Market Share by Application (2017-2022)

5.3 Global Toxin Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Allergan

6.1.1 Allergan Corporation Information

6.1.2 Allergan Description and Business Overview

6.1.3 Allergan Toxin Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Allergan Toxin Product Portfolio

6.1.5 Allergan Recent Developments/Updates

6.2 Ipsen

6.2.1 Ipsen Corporation Information

6.2.2 Ipsen Description and Business Overview

6.2.3 Ipsen Toxin Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Ipsen Toxin Product Portfolio

6.2.5 Ipsen Recent Developments/Updates

6.3 Medytox

6.3.1 Medytox Corporation Information

6.3.2 Medytox Description and Business Overview

6.3.3 Medytox Toxin Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Medytox Toxin Product Portfolio

6.3.5 Medytox Recent Developments/Updates

6.4 LIBP

6.4.1 LIBP Corporation Information

6.4.2 LIBP Description and Business Overview

6.4.3 LIBP Toxin Sales, Revenue and Gross Margin (2017-2022)

6.4.4 LIBP Toxin Product Portfolio

6.4.5 LIBP Recent Developments/Updates

6.5 Merz Pharmaceuticals

6.5.1 Merz Pharmaceuticals Corporation Information

6.5.2 Merz Pharmaceuticals Description and Business Overview

6.5.3 Merz Pharmaceuticals Toxin Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Merz Pharmaceuticals Toxin Product Portfolio

6.5.5 Merz Pharmaceuticals Recent Developments/Updates

6.6 US World Meds

6.6.1 US World Meds Corporation Information

6.6.2 US World Meds Description and Business Overview

6.6.3 US World Meds Toxin Sales, Revenue and Gross Margin (2017-2022)

6.6.4 US World Meds Toxin Product Portfolio

6.6.5 US World Meds Recent Developments/Updates

6.7 Hugel

6.6.1 Hugel Corporation Information

6.6.2 Hugel Description and Business Overview

6.6.3 Hugel Toxin Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Hugel Toxin Product Portfolio

6.7.5 Hugel Recent Developments/Updates

6.8 Daewoong

6.8.1 Daewoong Corporation Information

6.8.2 Daewoong Description and Business Overview

6.8.3 Daewoong Toxin Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Daewoong Toxin Product Portfolio

6.8.5 Daewoong Recent Developments/Updates

7 Toxin Manufacturing Cost Analysis

7.1 Toxin Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Toxin

7.4 Toxin Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Toxin Distributors List

8.3 Toxin Customers

9 Toxin Market Dynamics

9.1 Toxin Industry Trends

9.2 Toxin Market Drivers

9.3 Toxin Market Challenges

9.4 Toxin Market Restraints

10 Global Market Forecast

10.1 Toxin Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Toxin by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Toxin by Type (2023-2028)

10.2 Toxin Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Toxin by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Toxin by Application (2023-2028)

10.3 Toxin Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Toxin by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Toxin by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample